Ann-Hunter Van Kirk, Bloomberg Intelligence Senior Biopharmaceutical Analyst and co-author of the report, noted that improved ...

A class II risk level is given to products that "may cause temporary or medically reversible adverse health consequences." ...

CA1 is the first and only treatment for chemotherapy-induced diarrhea (CID) in dogs to receive any type of approval from the FDA ...

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a partnership with California-based Subtle ...

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a partnership with California-based Subtle Medical, Inc. (Subtle ...

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for TLX101-CDx ...

Biotech industry leaders added to the Board of Directors, bringing deep expertise in drug discovery, neuroscience clinical development, and ...

Read more about how Business Insider Reviews tests and researches pet products ... It lists all FDA- and EPA-approved parasite control products for small animals, including each product's active ...

According to the release, the United States Food and Drug Administration ... However there is currently no FDA-approved ...

Invion Therapeutics is deploying little known - but age old - photodynamic therapies to tackle a range of solid tumours ...

Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...